{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:51:29Z","timestamp":1767135089326,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd009027.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000}}],"reference-count":38,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009027.pub4","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T06:35:25Z","timestamp":1635748525000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antiepileptic drugs for seizure control in people with neurocysticercosis"],"prefix":"10.1002","volume":"2021","author":[{"given":"Dean","family":"Walton","sequence":"additional","affiliation":[{"name":"Department of Neurology; The Walton Centre NHS Foundation Trust; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Castell","sequence":"additional","affiliation":[{"name":"Department of Neurology; The Walton Centre NHS Foundation Trust; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ceryce","family":"Collie","sequence":"additional","affiliation":[{"name":"Department of Neurology; The Walton Centre NHS Foundation Trust; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greta Karen","family":"Wood","sequence":"additional","affiliation":[{"name":"Department of Neurology; The Walton Centre NHS Foundation Trust; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Christian Medical College; Ludhiana India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tejinder","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; SGRD Institute of Medical Sciences and Research; Amritsar India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedict D","family":"Michael","sequence":"additional","affiliation":[{"name":"Department of Neurology; The Walton Centre NHS Foundation Trust; Liverpool UK"},{"name":"Clinical Infection Microbiology and Neuroimmunology; Institute of Infection, Veterinary and Ecological Science; Liverpool UK"},{"name":"NIHR Health Protection Research Unit for Emerging and Zoonotic Infection; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD009027.pub4-BIB0001|cit1","first-page":"145","article-title":"Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain","volume":"50","author":"Gupta","year":"2002","journal-title":"Neurology India"},{"issue":"5","key":"10.1002\/14651858.CD009027.pub4-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/tropej\/49.5.274","article-title":"One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions","volume":"49","author":"Singhi","year":"2003","journal-title":"Journal of Tropical Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD009027.pub4-BIB0003|cit3","first-page":"141","article-title":"Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs?","volume":"50","author":"Thussu","year":"2002","journal-title":"Neurology India"},{"issue":"3","key":"10.1002\/14651858.CD009027.pub4-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1600-0404.2005.00538.x","article-title":"Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma","volume":"113","author":"Verma","year":"2006","journal-title":"Acta Neurologica Scandinavica"},{"issue":"4 Suppl 4","key":"10.1002\/14651858.CD009027.pub4-BIB0005|cit5","first-page":"A200, Abstract","article-title":"Tiagabine HCl may be effective in complex partial epilepsy due to neurocysticercosis","volume":"50","author":"Chang","year":"1998","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD009027.pub4-BIB0006|cit6","first-page":"157","article-title":"Safety and efficacy of clobazam versus phenytoin sodium in the anti-epileptic drug treatment of solitary cysticercus granulomas","volume":"54","author":"Kaushal","year":"2006","journal-title":"Neurology India"},{"issue":"3","key":"10.1002\/14651858.CD009027.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00007691-200206000-00003","article-title":"Pharmocokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis","volume":"24","author":"Lanchote","year":"2002","journal-title":"Therapeutic Drug Monitoring"},{"issue":"3","key":"10.1002\/14651858.CD009027.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/ane.13355","article-title":"Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis","volume":"143","author":"Santhosh","year":"2021","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD009027.pub4-BIB0009|cit9","unstructured":"A study comparing levetiracetam and valproic acid in preventing seizure in children diagnosed with neurocysticercosis ctri.nic.in\/Clinicaltrials\/showallp.php?mid1=30301&EncHid=&userName=CTRI\/2019\/01\/017368"},{"issue":"3","key":"10.1002\/14651858.CD009027.pub4-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000215.pub4","article-title":"Anthelmintics for people with neurocysticercosis","author":"Abba","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009027.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.7326\/0003-4819-144-2-200601170-00027","article-title":"Neurocysticercosis in Kansas","volume":"144","author":"Daniels","year":"2006","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009027.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1535-7597.2004.43008.x","article-title":"Neurocysticercoisis","volume":"4","author":"DeGiorgio","year":"2004","journal-title":"Epilepsy Currents"},{"issue":"2","key":"10.1002\/14651858.CD009027.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1212\/WNL.42.2.389","article-title":"Epilepsy due to neurocysticercosis: analysis of 203 patients","volume":"42","author":"Del Brutto","year":"1992","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD009027.pub4-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0896-6974(96)00022-9","article-title":"Discontinuation of antiepileptic drugs in patients with calcified neurocysticercosis","volume":"9","author":"Del Brutto","year":"1996","journal-title":"Journal of Epilepsy"},{"issue":"2","key":"10.1002\/14651858.CD009027.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.57.2.177","article-title":"Proposed diagnostic criteria for neurocysticercosis","volume":"57","author":"Del Brutto","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD009027.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.0013-9580.2005.36504.x","article-title":"Epilepsy and neurocysticercosis in Atahualpa: a door to door survey in rural coastal Ecuador","volume":"46","author":"Del Brutto","year":"2005","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD009027.pub4-BIB0017|cit17","unstructured":"Dhawan VK Pediatric neurocysticercosis emedicine.medscape.com\/article\/999053-overview#a0199"},{"issue":"4","key":"10.1002\/14651858.CD009027.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1590\/S0004-282X2002000600004","article-title":"Number and viability of parasite influence seizure frequency in children with neurocysticercosis","volume":"60","author":"Ferreira","year":"2002","journal-title":"Arquivos de Neuropsiquiatria"},{"issue":"4","key":"10.1002\/14651858.CD009027.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.15.4.747-756.2002","article-title":"Current consensus guidelines for treatment of neurocysticercosis","volume":"15","author":"Garc\u00eda","year":"2002","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1002\/14651858.CD009027.pub4-BIB0020|cit20","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD009027.pub4-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1111\/j.1528-1157.1992.tb06222.x","article-title":"Seizure disorders: the changes with age","volume":"33","author":"Hauser","year":"1992","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD009027.pub4-BIB0022|cit22","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD009027.pub4-BIB0023|cit23","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Technical supplement to chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD009027.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/0028-3886.30425","article-title":"Economic evaluation of seizures associated with solitary cysticercus granuloma","volume":"55","author":"Murthy","year":"2007","journal-title":"Neurology India"},{"issue":"2","key":"10.1002\/14651858.CD009027.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.68.2.137","article-title":"Neurocysticercosis and epilepsy in developing countries","volume":"68","author":"Pal","year":"2000","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD009027.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/j.1528-1157.1998.tb01333.x","article-title":"Neurocysticercosis in persons with epilepsy in Medellin, Colombia","volume":"39","author":"Palacio","year":"1998","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD009027.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1531-8249(200008)48:2<181::AID-ANA7>3.0.CO;2-C","article-title":"Perilesional gliosis and seizure outcome:a study based on magnetization transfer magnetic resonance imaging in patients with neurocysticercosis","volume":"48","author":"Pradhan","year":"2000","journal-title":"Annals of Neurology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009027.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1528-1157.44.s.1.10.x","article-title":"Solitary cerebral cysticercus granuloma","volume":"44","author":"Rajshekhar","year":"2003","journal-title":"Epilepsia"},{"issue":"12","key":"10.1002\/14651858.CD009027.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1212\/01.WNL.0000130471.19171.D8","article-title":"Seizure outcome in patients with a solitary cerebral cysticercus granuloma","volume":"62","author":"Rajshekhar","year":"2004","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD009027.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1212\/01.wnl.0000249113.11824.64","article-title":"Active epilepsy as an index of burden of neurocysticercosis in Vellore District, India","volume":"67","author":"Rajshekhar","year":"2006","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009027.pub4-BIB0031|cit31","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD009027.pub4-BIB0032|cit32","unstructured":"Review Manager 5 (RevMan 5) The Cochrane Collaboration 2020"},{"issue":"5","key":"10.1002\/14651858.CD009027.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/jnnp.61.5.433","article-title":"Epidemiology of the epilepsies","volume":"61","author":"Sander","year":"1996","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD009027.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/088307380001500401","article-title":"Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy","volume":"15","author":"Singhi","year":"2000","journal-title":"Journal of Child Neurology"},{"key":"10.1002\/14651858.CD009027.pub4-BIB0035|cit35","unstructured":"Zafar MJ Neurocysticercosis emedicine.medscape.com\/article\/1168656-overview#a0156"},{"issue":"10","key":"10.1002\/14651858.CD009027.pub4-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009027","article-title":"Antiepileptic drugs for seizure control in people with neurocysticercosis","author":"Frackowiak","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009027.pub4-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009027","article-title":"Drugs for seizure control in people with neurocysticercosis","author":"Sharma","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD009027.pub4-BIB0038|cit38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009027.pub2","article-title":"Antiepileptic drugs for seizure control in people with neurocysticercosis","author":"Sharma","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T09:17:38Z","timestamp":1749460658000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009027.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009027.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}